Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population

Table 3 Biochemical manifestations at diagnosis

Patient	Serum phosphate		Serum alkaline phosphatases (mU/ml)	Serum 1,25(OH)₂D (pg/ml)	Serum intact PTH (pg/ml)	TPR (%)
Patient	mg/dl	SDS	Serum alkaline phosphatases (mU/ml)	Serum 1,25(OH)₂D (pg/ml)	Serum intact PTH (pg/ml)	TPR (%)
I.1	3.4	− 2.21	1230	87	–	–
I.2	3.8	− 1.05	1916	76	–	–
II.1	2.6	− 2.68	695	57	81	79
III.1	2.1	− 3.36	1646	16	68	32
IV.1	2.8	− 2.41	378	73	29	78
IV.2	3.0	− 2.44	232	40	43	82
V.1	2.1	− 3.99	1513	147	78	85
VI.1	2.6	− 2.68	525	33	64	78
VII.1	–	–	–	–	–	–
VII.2	2.4	− 2.95	516	–	–	–
VII.3	–	–	991	28	30	–
VII.4	–	–	–	–	–	–
VIII.1	3.1	− 2.27	598	55	39	38
IX.1	3.0	− 2.44	1824	47	59	67
X.1	2.9	− 2.61	639	33	136	74
XI.1	2.3	− 3.09	–	–	58	–
XII.1	2.7	− 2.54	–	–	48	–
XIII.1	–	–	–	–	–	–
XIV.1	3.3	− 2.34	892	64	65	75
XV.1	2.0	− 3.49	704	20	–	39
XVI.1	2.4	− 3.47	571	108	71	26
XVII.1	2.5	− 3.30	–	28	30	–
XVIII.1	2.3	− 3.09	1864	31	64	73
XIX.1	–	–	–	–	–	–
XX.1	2.9	− 2.27	446	88	116	93
XXI.1	3.1	− 2.27	470	56	49	86
XXII.1	2.8	− 2.78	697	74	32	76
XXIII.1	2.1	− 3.36	733	–	68	82
XXIV.1	2.2	− 3.22	514	61	78	58
XXV.1	2.9	− 2.27	1940	40	57	58
XXVI.1	2.3	− 3.64	423	–	–	82
XXVII.1	2.9	− 2.86	432	31	23	–
XXVII.2	–	–	–	–	–	–
XXVIII.1	3.0	− 2.14	236	78	54	–
XXVIII.2	3.3	− 2.34	426	171	57	90
XXIX.1	1.8	− 3.77	1555	–	–	–
XXX.1	3.1	− 2.00	829	183	101	88
XXX.2	2.2	− 3.22	158	25	–	–
XXXI.1	–	–	–	–	–	–
XXXII.1	2.8	− 2.41	692	41	111	–
XXXIII.1	2.1	− 3.99	–	–	76	54
XXXIV.1	2.3	− 3.09	856	64	101	46
XXXV.1	3.5	− 2.08	916	–	227	82
XXXV.2	2.2	− 3.22	1620	–	–	70
XXXVI.1	2.8	− 2.41	1093	65	66	–
XXXVII.1	2.4	− 2.95	1527	46	94	–
XXXVIII.1	2.4	− 2.95	856	40	58	–
XXXIX.1	3.0	− 2.14	759	51	43	–

1,25(OH)₂D: 1,25 dihydroxyvitamin D. PTH: Parathyroid hormone
TPR: tubular phosphate reabsorption. Dash: information in this field was missing from the database

ISSN: 1750-1172